Stock listing

Biovaxys Technology Corp

Selected listing: A41C58 · LS · EUR · DE

Biovaxys Technology Corp (Lang & Schwarz: A41C58), Non-Energy Minerals. Latest release Sep 8, 2026: BioVaxys Technology Corp. to Present at the Moody Capital…

A41C58:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A41C58
Asset type: Stock
Sector: Non-Energy Minerals
Industry: Other Metals/Minerals
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Biovaxys Technology Corp

BioVaxys Technology Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

September 8, 2026

BioVaxys Presents Further Validation of the Robust Immune Response from a Combination of MVP-S with Checkpoint Inhibitors and Low-Dose Cyclophosphamide in Ovarian Cancer

May 1, 2026

BioVaxys Announces Phase I/II PESCO Trial Abstract Accepted for Presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

April 27, 2026

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

March 17, 2026

BioVaxys Announces Application for Management Cease Trade Order

March 3, 2026

All Biovaxys Technology Corp news →

Research Biovaxys Technology Corp

Biovaxys Technology Corp company profile

View the public company page for Biovaxys Technology Corp on 6ix.

Biovaxys Technology Corp news

Read company news and market updates connected to Biovaxys Technology Corp.

Biovaxys Technology Corp investor events

Find investor webinars, events, and replay context for Biovaxys Technology Corp.